New study reveals how psoriasis drug enters breast milk
NCT ID NCT06476834
First seen Jan 04, 2026 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This completed Phase 4 study looked at how much deucravacitinib (SOTYKTU®), a drug for plaque psoriasis, passes into breast milk. Eight healthy lactating women took a single dose, and researchers measured drug levels in their milk and blood. The goal was to estimate how much of the drug a nursing infant might consume, helping guide future recommendations for breastfeeding mothers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Las Vegas, Nevada, 89113-2246, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Deucravacitinib (SOTYKTU®)
What this could lead to
If successful, this study could help doctors understand how much deucravacitinib passes into breast milk, guiding safer use during breastfeeding.
What could go wrong
This is a very small study (8 participants) in healthy volunteers, not patients. Results may not apply to all women or those with medical conditions.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.